:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autore principale:	Cancel Asencio, Héctor
Natura:	Recurso digital
Lingua:	inglese
Pubblicazione:	Zenodo 2024
Soggetti:	Alzheimer Disease
Accesso online:	https://doi.org/10.5281/zenodo.15838602
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer’s Diseases
di: Kassim Adebambo, et al.
Pubblicazione: (2024)

Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer’s Disease
di: Samat Kozhakhmetov, et al.
Pubblicazione: (2024)

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology
di: Nicholas R. Ray, et al.
Pubblicazione: (2024)

Navigating late‐stage dementia: A perspective from the Alzheimer's Association
di: Kristen Clifford, et al.
Pubblicazione: (2024)

Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
di: María A. Rodríguez‐Santiago, et al.
Pubblicazione: (2024)

Allostatic load dynamics, Alzheimer's disease biomarkers, and progression in individuals with mild cognitive impairment: findings from the Alzheimer's Disease Neuroimaging Initiative
di: Juliana N. Souza‐Talarico, et al.
Pubblicazione: (2025)

Diagnostic performance of light reflex pupillometry in Alzheimer's disease
di: Mathias Holsey Gramkow, et al.
Pubblicazione: (2024)

The family caregiver’s discourse on the hospitalization of the elderly with Alzheimer’s disease
di: Gabriela Pizelli Mocco Grillo
Pubblicazione: (2017)

Association between BrainAGE and Alzheimer's disease biomarkers
di: Yousaf Abughofah, et al.
Pubblicazione: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
di: Thomas Claessen, et al.
Pubblicazione: (2025)

Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease
di: Diana Esteller‐Gauxax, et al.
Pubblicazione: (2026)

Treating Alzheimer's disease in a person living with HIV
di: David B. Clifford, et al.
Pubblicazione: (2026)

Interchangeability of CSF and PET to identify Alzheimer's disease pathology
di: Samantha C. Burnham, et al.
Pubblicazione: (2026)

A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
di: Sara Teijeira‐Portas, et al.
Pubblicazione: (2026)

Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease
di: Peter Thomas, et al.
Pubblicazione: (2024)

Longitudinal changes in functional capacity in frontotemporal dementia and Alzheimer's disease
di: David Foxe, et al.
Pubblicazione: (2024)

Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease
di: Sofia Toniolo, et al.
Pubblicazione: (2024)

Day‐to‐day sleep variability with Alzheimer's biomarkers in at‐risk elderly
di: Andrée‐Ann Baril, et al.
Pubblicazione: (2024)

Cerebrospinal fluid sclerostin levels in the early Alzheimer's disease stages
di: Manuela Dicarlo, et al.
Pubblicazione: (2026)

Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints
di: Alisa Bannerjee, et al.
Pubblicazione: (2025)

Caregivers’ attitudes toward blood‐based biomarker testing for Alzheimer's disease
di: Katharina Bolsewig, et al.
Pubblicazione: (2024)

Non‐Alzheimer's amnestic mild cognitive impairment with medial temporal hypometabolism
di: Sebastiaan De Keersmaecker, et al.
Pubblicazione: (2024)

Commentary on “It is time to share Alzheimer biomarker results in dementia with Lewy bodies”
di: John T. O'Brien
Pubblicazione: (2025)

Poor dream recall associates with Alzheimer's disease biomarkers and dementia risk
di: Darren M. Lipnicki, et al.
Pubblicazione: (2026)

Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West
di: Bethany C. Curd, et al.
Pubblicazione: (2026)

Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's disease
di: Ying Xia, et al.
Pubblicazione: (2025)

Machine learning models of Alzheimer's disease spectrum using blood tests
di: Nicola Walter Falasca, et al.
Pubblicazione: (2025)

Sensory changes in preclinical, prodromal, and clinical Alzheimer's disease and related dementias
di: Willa D. Brenowitz, et al.
Pubblicazione: (2026)

Effects of obesity on plasma biomarker and amyloid PET trajectories in Alzheimer's disease
di: Soheil Mohammadi, et al.
Pubblicazione: (2025)

White matter hyperintensities in Alzheimer's disease in the era of anti‐amyloid therapies
di: Antoine Garnier‐Crussard, et al.
Pubblicazione: (2026)

Serum biomarkers as prognostic markers for Alzheimer's disease in a clinical setting
di: Steffi De Meyer, et al.
Pubblicazione: (2025)

The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndrome
di: Julianne G. Clina, et al.
Pubblicazione: (2026)

A Bayesian analysis of diagnostic timelines across Alzheimer's disease, frontotemporal dementia, and other neurodegenerative conditions
di: Ananthan Ambikairajah, et al.
Pubblicazione: (2025)

Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990–2021: A systematic analysis for the Global Burden of Disease study 2021
di: Fang Wang, et al.
Pubblicazione: (2025)

Letter response to Clifford et al. “Navigating late‐stage dementia: A perspective from the Alzheimer's Association”
di: Stanley Arnold Terman, et al.
Pubblicazione: (2024)

Peripheral oxidative stress related biomarkers in Alzheimer's disease: A systematic review of their implications for diagnosis and disease monitoring
di: George Nkrumah Osei, et al.
Pubblicazione: (2026)

Temporal comorbidity patterns in Alzheimer's disease and vascular dementia: A population‐based observational study in UK Biobank
di: Chloe Walsh, et al.
Pubblicazione: (2026)

Increased risk of infusion‐related reactions switching between monoclonal antibodies for Alzheimer's disease: A case series
di: Ganesh Gopalakrishna, et al.
Pubblicazione: (2026)

Assessing Alzheimer's disease via plasma extracellular vesicle–derived mRNA
di: Le Hoang Phu Pham, et al.
Pubblicazione: (2024)

Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
di: Hossein Moein Taghavi, et al.
Pubblicazione: (2024)